Fundacio Hospital Universitari Vall D'Hebron Institut De Recerca

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease	Abnormalities, Multiple, Ciliopathies, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, autosomal dominant polycystic kidney disease, cystic kidney disease, hereditary disease, kidney disorder, polycystic kidney disease, urinary system disorder	Recruiting	Phase 3	2026-07-28		NCT07280585

Clinical trials